- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Malignant Melanoma, Neoplasms in United Kingdom
Total 49553 results
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bristol-Myers SquibbActive, not recruitingMetastatic Uveal Melanoma | Metastatic Malignant Neoplasm in the Liver | Stage IV Uveal Melanoma AJCC v7United States
-
University of ChicagoStand Up To CancerRecruitingCancer | Malignant Neoplasm | MalignancyUnited States
-
Thomas Jefferson UniversityRecruitingMetastatic Uveal Melanoma | Metastatic Malignant Neoplasm in the Liver | Stage IV Choroidal and Ciliary Body Melanoma AJCC V8United States
-
Agenus Inc.CompletedMalignant MelanomaUnited States, Australia, Poland, Ukraine, United Kingdom, Russian Federation, Hungary, Italy, Sweden
-
Immunovia, Inc.CompletedPancreatic Ductal Adenocarcinoma | Familial Pancreatic Cancer | FAMMM - Familial Atypical Mole Malignant Melanoma SyndromeUnited States, Sweden, Canada, Spain, United Kingdom
-
Royal Liverpool University HospitalUnknownMelanoma | Eye Neoplasms | Choroidal MelanomaUnited Kingdom
-
Royal Marsden NHS Foundation TrustUniversity of Leeds; University of ManchesterTerminated
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Cutaneous MelanomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Melanoma | Metastatic Malignant Neoplasm in the Brain | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
University of OxfordNatera, Inc.; Immunocore LtdRecruitingMelanoma (Skin) | Melanoma, UvealUnited Kingdom
-
The Christie NHS Foundation TrustUniversity of ManchesterRecruiting
-
Richard WuIovance Biotherapeutics, Inc.Active, not recruitingLocally Advanced Melanoma | Stage IV Melanoma | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8United States
-
The Christie NHS Foundation TrustBristol-Myers Squibb; University of Manchester; Manchester Academic Health Science...Active, not recruiting
-
Vitaccess LtdRoyal Marsden NHS Foundation Trust; Melanoma UKCompleted
-
Moletest Scotland LtdNHS Lanarkshire; Digital Health & Care InstituteCompleted
-
Bristol-Myers SquibbCompleted
-
Immodulon Therapeutics LtdTheradex; HCA International LimitedCompleted
-
TC BiopharmTerminatedNon-small Cell Lung Cancer | Renal Cell Cancer | Malignant MelanomaUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Oxford; National Institute for Health Research, United Kingdom; Oxford University Hospitals NHS TrustCompleted
-
University of OxfordUnknown
-
University of Illinois at ChicagoMillennium Pharmaceuticals, Inc.CompletedMelanoma | Head and Neck Neoplasms | Malignant Neoplasm of Breast | Malignant Neoplasm of Thorax | CNS Malignancy | Malignant Neoplasm of Gastrointestinal Tract | Genitourinary Neoplasms Malignancy and Gender UnspecifiedUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingMetastatic Melanoma | Stage III Lung Cancer AJCC v8 | Metastatic Lung Carcinoma | Stage IV Lung Cancer AJCC v8 | Locally Advanced Malignant Solid Neoplasm | Locally Advanced Melanoma | Metastatic Malignant Solid Neoplasm | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Glioblastoma | Metastatic Melanoma | Recurrent Malignant Glioma | Metastatic Malignant Neoplasm in the Brain | Recurrent Brain NeoplasmUnited States
-
CCTU- Cancer ThemePierre Fabre MedicamentNot yet recruitingMelanoma | CancerUnited Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGenetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV MelanomaMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRefractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Cutaneous Melanoma | Recurrent Malignant Female Reproductive System Neoplasm | Refractory Malignant Female Reproductive System Neoplasm | Recurrent Lip and Oral Cavity Carcinoma | Recurrent Malignant Endocrine... and other conditionsUnited States
-
Royal Free Hospital NHS Foundation TrustMerck Sharp & Dohme LLC; University College, LondonCompletedMelanoma | NeoplasmsUnited Kingdom
-
VicalCompletedMelanoma | Skin Cancer | Metastatic Melanoma | Malignant MelanomaUnited States
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingGlioma | Melanoma | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Neoplasms by Site | Cancer | Brain Neoplasms | Solid Tumor | Malignant Neoplasm | Malignancy | Haematological MalignancyUnited Kingdom
-
University of SurreyCompleted
-
National Cancer Institute (NCI)Active, not recruitingStage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Unresectable MelanomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Metastatic Malignant Solid Neoplasm | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Solid Neoplasm | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma... and other conditionsUnited States
-
Orlucent, IncUniversity Hospitals, Leicester; NHS Tayside; University of Dundee; NHS Greater... and other collaboratorsCompletedMelanoma | Skin Lesion | MolesUnited Kingdom
-
Millennium Pharmaceuticals, Inc.CompletedMelanoma | Solid Tumor | Metastatic Melanoma | NeoplasmUnited States, United Kingdom
-
Imperial College LondonRecruiting
-
Immuneering CorporationRecruitingPancreas Adenocarcinoma | Non-small Cell Lung Cancer | Advanced Solid Tumor (Phase 1) | Malignant Melanoma (Cutaneous)United States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMelanoma of Unknown Primary | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Recurrent Cutaneous Melanoma | Metastatic Malignant Neoplasm in Lymph NodeUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable MelanomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingUnresectable Cutaneous Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Melanoma of Unknown Primary | Mucosal Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
Jerry MarsdenDepartment of Health, United KingdomCompleted
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Recurrent Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
National Cancer Institute (NCI)CompletedStage IV Uveal Melanoma AJCC v7 | Recurrent Uveal MelanomaUnited States, France, United Kingdom
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIUnited States, Netherlands, Australia
-
University of Colorado, DenverKarsh Family Research FundActive, not recruitingHead and Neck Cancer | Malignant MelanomaUnited States
-
University of AberdeenCancer Research UKCompletedMelanomaUnited Kingdom
-
European Organisation for Research and Treatment...TerminatedMetastatic Cancer | Intraocular MelanomaSwitzerland, Italy, United Kingdom, Poland
-
National Cancer Institute (NCI)RecruitingStage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Refractory Melanoma | BRAF V600 Wild Type | Intracranial MelanomaUnited States
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
Novartis PharmaceuticalsCompletedUveal MelanomaUnited Kingdom, France, Netherlands, United States